Forward Earnings Estimates
FY+1 EPS Consensus~$0.42 (FY2027E non-GAAP, est.; quarterly guide of $0.16 actual + $0.02/$0.10/$0.10)
FY+2 EPS Consensus~$0.85 (FY2028E non-GAAP, est. — roughly doubling on operating leverage)
PEG RatioN/M on GAAP (losses); on non-GAAP forward EPS the multiple is high but ARR-growth-adjusted it is reasonable for the cohort
Forward P/EVery high / N/M on FY2027E non-GAAP EPS (~$0.42) — the stock is valued on ~7.5x forward sales and FCF, not near-term EPS
EPS Revisions (90d)↑12 ↓1 (Strongly positive — estimates and price targets revised up broadly after the Q1 FY2027 beat-and-raise (Scotiabank, Cantor, Truist, KeyBanc, Baird, BMO all lifted targets))
Guidance AccuracyStrong — RBRK has beaten and raised in each of its recent public quarters (Q3'26, Q4'26, Q1'27), exceeding all guided metrics in Q1'27
Earnings Surprise Track Record
Q1 FY2027
Est: −$0.03
Act: +$0.16
Beat by $0.19; revenue $387.1M vs ~$373.6M est.
Q4 FY2026
Est: ~−$0.05 (est.)
Act: Beat; revenue $377.7M vs ~$341-343M guide
Revenue & ARR above guide
Q3 FY2026
Est: ~−$0.20 (est.)
Act: Beat; revenue $350.2M (+48%)
Record net-new ARR
Q2 FY2026
Est: ~−$0.35 (est.)
Act: Beat; revenue $309.9M (+51%)
Beat and raised
Beat Rate4 of 4 recent quarters beat on revenue; Q1 FY2027 was a large EPS beat (+$0.16 vs −$0.03)